Innovative Research Award

Carmen Elena Gómez
National Biotechnology Center | CSIC

          Carmen Elena Gómez
Affiliation National Biotechnology Center | CSIC
Country Spain
Scopus ID 35796367700
Documents 291
Citations 10,146
h-index 47
Subject Area Vaccine
Event Global Diseases Research Awards
ORCID 0000-0002-9473-283X

Carmen Elena Gómez is a researcher affiliated with the National Biotechnology Center of the Spanish National Research Council (CSIC), Spain. Her scientific activities focus on vaccine research, biotechnology, and biomedical innovation. The Innovative Research Award recognizes distinguished contributions in developing impactful scientific approaches and advancing research knowledge within the global health landscape. Research profiles and publication records are evaluated through internationally recognized scholarly databases including Scopus.[1]

Abstract

The Innovative Research Award highlights researchers whose scientific achievements contribute to advances in biomedical sciences and healthcare innovation. Carmen Elena Gómez has established a research profile associated with vaccine development and biotechnology, supported by extensive scholarly publications, citation impact, and international scientific recognition. Her work represents contributions toward understanding and improving vaccine technologies for public health applications.[1]

Keywords

Vaccine Research, Biotechnology Innovation, Immunology, Biomedical Research and Scientific Excellence. [2]

Introduction

Vaccines represent a major area of biomedical research aimed at preventing infectious diseases and improving population health outcomes. Researchers working in vaccine science contribute through immunological studies, platform development, translational research, and evaluation of novel strategies. Carmen Elena Gómez’s academic contributions align with these objectives through research activities documented in international scientific databases.[2]

Research Profile

The researcher profile indicates affiliation with the National Biotechnology Center | CSIC in Spain. According to Scopus indexing information, the profile includes 291 documents, 10,146 citations, and an h-index of 47, reflecting a sustained research presence within the scientific literature.[1]

Research Contributions

The research contributions associated with vaccine science include investigations into vaccine platforms, immune responses, and biotechnology-based approaches. Such research supports the broader scientific objective of improving preventive healthcare strategies and strengthening preparedness against infectious diseases.[3]

Publications

The publication record of Carmen Elena Gómez includes peer-reviewed scientific outputs indexed within international research databases. These publications contribute to the understanding of vaccine technologies, molecular biology, and biomedical applications. Selected publications may include DOI-based identification for reliable scholarly access.[4]

Research Impact

Research impact is reflected through citation metrics, publication activity, and contributions to scientific knowledge. The citation count and h-index provide quantitative indicators of academic influence while recognizing that research quality is assessed through broader scholarly evaluation methods.[1]

Award Suitability

The Innovative Research Award acknowledges researchers demonstrating meaningful scientific contributions and advancement of knowledge. Carmen Elena Gómez’s documented research activity in vaccine science, supported by academic publications and measurable research indicators, aligns with the objectives of this recognition category. [2]

Conclusion

Carmen Elena Gómez represents a scientific profile associated with vaccine research and biotechnology innovation. Her academic record, publication activity, and research impact demonstrate continued engagement with internationally recognized biomedical research efforts.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Carmen Elena Gómez, Author ID 35796367700. Scopus.https://www.scopus.com/authid/detail.uri?authorId=35796367700
  2. Global Diseases Research Awards. (2026). Innovative Research Award.
    https://globaldiseases.org/
  3. Delaloye, J., Roger, T., Steiner-Tardivel, Q.-G., Le Roy, D., Knaup Reymond, M., Akira, S., Petrilli, V., Gomez, C. E., Perdiguero, B., Tschopp, J., Pantaleo, G., Esteban, M., & Calandra, T. (2009). Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathogens, 5(6), e1000480.
    https://doi.org/10.1371/journal.ppat.1000480
  4. Gómez, C. E., Perdiguero, B., & Esteban, M. (2021). Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2/COVID-19. Vaccines, 9(3), 243.
    https://doi.org/10.3390/vaccines9030243
  5. Gili, V. F., Carletti, L., Locatelli, A., Rocco, D., Finazzi, M., Ghirardini, L., Favero, I., Gomez, C., Lemaître, A., Celebrano, M., De Angelis, C., & Leo, G. (2016). Monolithic AlGaAs second-harmonic nanoantennas. Optics Express, 24(14), 15965–15975.
    https://doi.org/10.1364/OE.24.015965
Carmen Elena Gómez | Vaccine | Innovative Research Award

You May Also Like